Successful pembrolizumab treatment of microsatellite instability-high
intrahepatic cholangiocarcinoma: A case report
Pembrolizumab is considered to be an effective therapy for patients with
microsatellite instability (MSI)-high cancer. Here, we report a case of
MSI-high cholangiocarcinoma effectively treated with pembrolizumab. MSI
status should be actively evaluated in patients with cholangiocarcinoma.